Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H9Cl2N3O2 |
Molecular Weight | 214.05 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ClCCNC(=O)N(CCCl)N=O
InChI
InChIKey=DLGOEMSEDOSKAD-UHFFFAOYSA-N
InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)
Molecular Formula | C5H9Cl2N3O2 |
Molecular Weight | 214.05 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:18 UTC 2023
by
admin
on
Fri Dec 15 15:02:18 UTC 2023
|
Record UNII |
U68WG3173Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C699
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
LIVERTOX |
NBK548307
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
FDA ORPHAN DRUG |
37089
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
WHO-ATC |
L01AD01
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
NDF-RT |
N0000000236
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
NDF-RT |
N0000175558
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
WHO-VATC |
QL01AD01
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
FDA ORPHAN DRUG |
606517
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
FDA ORPHAN DRUG |
134500
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/02/085
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
||
|
FDA ORPHAN DRUG |
801420
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
U68WG3173Y
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
DTXSID8022743
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
2959
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
U68WG3173Y
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
CARMUSTINE
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
205-838-2
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
D002330
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
512
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
C349
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
2578
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
100000090209
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
3423
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
6800
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
m3115
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB00262
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL513
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
2105
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
154-93-8
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
SUB06132MIG
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
1096724
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
Carmustine
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
7761
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY | |||
|
409962
Created by
admin on Fri Dec 15 15:02:18 UTC 2023 , Edited by admin on Fri Dec 15 15:02:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (UV)
EP
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
solvent-free basis
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (TLC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (GC)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||